Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × veliparib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Glioblastoma 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Renal Insufficiency 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lung Neoplasms 1 Liver Failure 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Astrocytoma 1 Ann Arbor Stage III Non-Hodgkin Lymphoma 1 Advanced Malignant Solid Neoplasm 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 4 Biopsy 4 Specimen Handling 3 ruxolitinib 2 mogamulizumab 2 Vincristine 2 Prednisone 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 tofacitinib 1 tazemetostat 1 talimogene laherparepvec 1 sodium-iodide symporter 1 hypericin 1 fludarabine phosphate 1 fludarabine 1 cemiplimab 1 belinostat 1 X-Rays 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Radiotherapy 1 Photons 1 Pharmacogenomic Variants 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 MEDI-570 1 Ipilimumab 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡